REFERENCES
- Levin J, Poore T, Zauber N, Oser R. Detection of endotoxin in the blood of patients with sepsis due to gram-negative bacteria. N Engl J Med.. 1970; 283: 1313–1316. [PUBMED], [INFOTRIEVE]
- Bone R, Fisher C, Jr, Clemmer T, Slotman G, Metz C, Balk R. Sepsis syndrome: a valid clinical entity: Methylprednisolone Severe Sepsis Study Group. Crit Care Med.. 1989; 17: 389–393. [PUBMED], [INFOTRIEVE]
- Niederman M, Fein A. Sepsis syndrome, the adult respiratory distress syndrome, and nosocomial pneumonia: a common clinical sequence. Clin Chest Med.. 1990; 11: 633–656. [PUBMED], [INFOTRIEVE]
- Zhang P, Bagby G, Stoltz D, Summer W, Nelson S. Enhancement of peritoneal leukocytes function by granulocyte colony-stimulating factor in rats with abdominal sepsis. Crit Care Med.. 1998; 26: 315–321. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Dixon RA, Diehl RE, Opas E. et al:. Requirement of a 5-lipoxygenase-activating protein for leukotriene synthesis. Nature. 1990; 343: 282–284. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Ford-Hutchinson AW. Modification of the lipoxygenase pathway of arachidonic acid metabolism, In:. Samuelsson B, et al:. Advances in Prostaglandin, Thromboxane, and Leukotriene Research. Vol. 20, New York, Raven Press. 1990; 161–169
- Samuelsson B. Leukotrienes: mediators of immediate hypersensitivity reactions and inflammation. Science. 1983; 220: 568–575. [PUBMED], [INFOTRIEVE]
- Lewis R, Austen K, Soberman R. Leukotrienes and other products of the 5-lipoxygenase pathway: biochemistry and relation to pathobiology in human disease. N Engl J Med.. 1990; 323: 645–655. [PUBMED], [INFOTRIEVE]
- Drazen J, Israel E, O'Byrne P. Treatment of asthma with drugs modifying the leukotriene pathway. NEngl J Med.. 1999; 340: 197–206. [CROSSREF]
- Stephenson A, Lonigro A, Hyers T, Webster R, Fowler A. Increased concentrations of leukotrienes in bronchoalveolar lavage fluid of patients with ARDS or risk of ARDS. Am Rev Respir Dis.. 1988; 138: 714–719. [PUBMED], [INFOTRIEVE]
- Hopkins H, Stull T, Von Essen S, Robbins R, Rennard S. Neutrophil chemotactic factors in bacterial pneumonia. Chest. 1989; 95: 1021–1027. [PUBMED], [INFOTRIEVE]
- Demitsu T, Katayama H, Saito-Taki T, Yaoita H, Nakano M. Phagocytosis and bactericidal action of mouse peritoneal macrophages treated with leukotriene B4. Int J Immunopharmacol. 1989; 11: 801–808. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Bailie M, Standiford T, Laichalk L, Coffey M, Strieter R, Peters-Golden M. Leukotriene-deficient mice manifest enhanced lethality from Klebsiella pneumonia in association with decreased alveolar macrophage phagocytic and bactericidal activities. J Immunol.. 1996; 157: 5221–5224. [PUBMED], [INFOTRIEVE]
- Mancuso P, Standiford T, Marshal T, Peters-Golden M. 5-lipoxygenase reaction products modulate alveolar macrophage phagocytosis of Klebsiella pneumoniae. Infect Immun.. 1998; 66: 5140–5146. [PUBMED], [INFOTRIEVE], [CSA]
- Moncada S, Palmer R, Higgs E. Nitric oxide: physiology,pathophysiology, and pharmacology. Pharmacol Rev.. 1991; 43: 109–142. [PUBMED], [INFOTRIEVE]
- Gaston B, Drazen J, Loscalzo J, Stamler J. The biology of nitrogen oxides in the airways. Am J Respir Crit Care Med.. 1994; 149: 538–551. [PUBMED], [INFOTRIEVE]
- Raychaudhuri B, Dweik R, Connors M. et al:. Nitric Oxide blocks nuclear factor-κ B activation in alveolar macrophages. Am J Respir Cell Mol Biol.. 1999; 21: 311–316. [PUBMED], [INFOTRIEVE], [CSA]
- Rovira I. Use of nitric oxide in acute respiratory failure. Clin Pulm Med.. 1999; 6: 187–194
- Salvemini D, Misko T, Masferrer J, Seibert K, Currie M. Nitric Oxide activates cyclooxygenase enzymes. Proc Natl Acad Sci USA. 1993; 90: 7240–7244. [PUBMED], [INFOTRIEVE]
- Feng L, Xia Y, Garcia G, Hwang D, Wilson C. Involvement of reactive oxygen intermediates in cyclooxygenase-2 expression induced by interleukin-1, tumor necrosis factor-α, and lipopolysaccharide. J Clin Invest.. 1995; 95: 1669–1675. [PUBMED], [INFOTRIEVE], [CSA]
- Stadler J, Harbrecht B, DiSilvio M. et al:. Endogenous nitric oxide inhibits the synthesis of cyclooxygenase products and interleukin 6 by rat Kupffer cells. J Leukoc Biol.. 1993; 53: 165–172. [PUBMED], [INFOTRIEVE], [CSA]
- Coffey M, Phare S. Peters-Golden M: Prolonged exposure to lipopolysaccharide inhibits macrophage 5-lipoxygenase metabolism via induction of nitric oxide synthesis. J Immunol.. 2000; 165: 3592–3598. [PUBMED], [INFOTRIEVE]
- Coffey M, Peters-Golden M, Fantone J, Sporn P. Membrane association of active 5-lipoxygenase in resting cells: evidence for novel regulation of the enzyme in the rat alveolar macrophage. J Biol Chem.. 1992; 267: 570–576. [PUBMED], [INFOTRIEVE]
- Peters-Golden M, McNish RW, Hyzy R, Shelly C, Toews GB. Alterations in the pattern of arachidonate metabolism accompany rat macrophage differentiation in the lung. J Immunol.. 1990; 144: 263–270. [PUBMED], [INFOTRIEVE]
- Kristof A, Goldberg P, Laubach V, Hussain S. Role of inducible nitric oxide synthase in endotoxin-induced acute lung injury. Am J Respir Crit Care Med.. 1998; 158: 1883–1889. [PUBMED], [INFOTRIEVE], [CSA]
- Coffey M, Wilcoxen S, Peters-Golden M. Increases in 5-lipoxygenase activating protein expression account for enhanced capacity for 5-lipoxygenase metabolism which accompanies differentiation of peripheral blood monocytes into alveolar macrophages. Am J Respir Cell Mol Biol.. 1994; 11: 153–158. [PUBMED], [INFOTRIEVE]
- Laemmli U. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970; 227: 680–685. [PUBMED], [INFOTRIEVE]
- Buccellati C, Rossoni G, Bonazzi A. et al:. Nitric oxide modulation of transcellular biosynthesis of cys-leukotrienes in rabbit leukocyte-perfused heart. B J Pharmacol. 1997; 120: 1128–1134. [CSA]
- Moore W, Webber R, Jerome G, Tjoeng F, Misko T, Currie M. L-N6-(1-iminoethyl)lysine: a selective inhibitor of inducible nitric oxide synthase. J Med. Chem.. 1994; 37: 3886–3888. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Coffey M, Phare S, Peters-Golden M. Peroxynitrite-induced nitrotyrosination of proteins is blocked by direct 5-lipoxygenase inhibitor zileuton. J Pharmacol Exp Ther.. 2001; 299: 198–203. [PUBMED], [INFOTRIEVE], [CSA]
- Martin E, Nathan C, Xie Q. Role of interferon regulatory factor 1 in induction of nitric oxide synthase, J Exp Med.. 1994; 180: 977–984
- Brunn G, Hey C, Wessler I, Racke K. Endogenous nitric oxide inhibits leukotriene B4 release from alveolar macrophages. Eur J Pharmacol.. 1997; 326: 53–60. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Coffey M, Phare S, Peters-Golden M. Interaction between nitric oxide, reactive oxygen intermediates, and peroxynitrite in the regulation of 5-lipoxygenase metabolism. Biochim Biophys Acta.. 2002; 1584: 81–90. [PUBMED], [INFOTRIEVE]
- Bergamini A, Bolacchi F, Bongiovanni B. et al:. Granulocyte-macrophage colony-stimulating factor regulates cytokine production in cultured macrophages through CD14-dependent and -independent mechanisms. Immunology. 2000; 101: 254–261. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Ring W, Riddick C, Baker J, Munafo D, Bigby T. Lymphocytes stimulate expression of 5-lipoxygenase and its activating protein in monocytes in vitro via granulocyte macrophage colony-stimulating factor and interleukin 3. J Clin Invest.. 1996; 97: 1293–1301. [PUBMED], [INFOTRIEVE], [CSA]
- Coffey M, Phare S, Cinti S, Peters-Golden M, Kazanjian P. Granulocyte-macrophage colonizing-stimulating factor upregulates the defect in 5-lipoxygenase metabolism in neutrophils and monocytes in AIDS. Blood. 1999; 94: 3897–3905. [PUBMED], [INFOTRIEVE], [CSA]
- Meslier N, Aldrich A, Bigby T. Effect of interferon-gamma on the 5-lipoxygenase pathway of rat lung macrophages. Am J Respir Cell Mol Biol.. 1992; 6: 93–99. [PUBMED], [INFOTRIEVE]
- Stokes K, Clanton E, Clements K, Granger D. Role of interferon-gamma in hypercholesterolemia-induced leukocyte-endothelial cell adhesion. Circulation. 2003; 107: 2140–2145. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Brock T, McNish R, Bailie M, Peters-Golden M. Rapid import of cytosolic 5-lipoxygenase into the nucleus of neutrophils after in vivo recruitment and in vitro adherence. J Biol Chem.. 1997; 272: 8276–8280. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Yin K, Hock C, Lai P, Ross J, Yue G. Role of interferon-gamma in lung inflammation following cecal ligation and puncture in rats. Shock.. 1999; 12: 215–221. [PUBMED], [INFOTRIEVE]
- Okamoto I, Abe M, Shibata K. et al:. Evaluating the role of inducible nitric oxide synthase using a novel and selective inducible nitric oxide synthase inhibitor in septic lung injury produced by cecal ligation and puncture. Am J Respir Crit Care Med.. 2000; 162: 716–722. [PUBMED], [INFOTRIEVE], [CSA]
- Benjamim C, Ferreira S, Cunha F. Role of nitric oxide in the failure of neutrophil migration in sepsis. J Infect Dis.. 2000; 182: 214–223. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Benjamim C, Silva J, Fortes Z, Oliveira M, Ferreira S, Cunha F. Inhibition of leukocyte rolling by nitric oxide during sepsis leads to reduced migration of active microbicidal neutrophils. Infect Immun.. 2002; 70: 3602–3610. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Goya T, Abe M, Shimura H, Torisu M. Characteristics of alveolar macrophages in experimental septic lung. J Leukoc Biol.. 1992; 52: 236–243. [PUBMED], [INFOTRIEVE], [CSA]
- Rios-Santos F, Benjamim C, Zavery D, Ferreira S, Cunha F. A critical role of leukotriene B4 in neutrophil migration to infectious focus in cecal ligaton and puncture sepsis. Shock. 2003; 19: 61–65. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Brock T, McNish R, Mancuso P, Coffey M, Peters-Golden M. Prolonged lipopolysaccharide inhibits leukotriene synthesis in peritoneal macrophages:mediation by nitric oxide and prostaglandins. Prostaglandins and Other Lipid Mediators. 2003; 71: 131–145. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Fermor B, Haribabu B, Weinberg JB, Pisetsky DS, Guilak F. Mechanical stress and nitric oxide influence leukotriene production in cartilage. Biochem Biophys Res Commun. 285. 2001; 806–810. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]